The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Updated results from a phase 2 trial.
 
Chung-Han Lee
Honoraria - American Institute of Continuing Medical Education; Ideology Health; Intellisphere; Medscape; Research to Practice
Consulting or Advisory Role - AVEO; Bristol-Myers Squibb; Cardinal Health; Eisai; Eisai; Exelixis; Merck; Pfizer/EMD Serono
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Eisai (Inst); Exelixis (Inst); Merck (Inst)
 
Kelly N. Fitzgerald
Consulting or Advisory Role - Janssen; MJH Life Sciences
 
Martin H Voss
Stock and Other Ownership Interests - CellGenix (I)
Consulting or Advisory Role - Affimed Therapeutics; AVEO; Eisai; Exelixis; Genentech; Merck; MicuRx Pharmaceuticals; Oncorena
Research Funding - Pfizer
(OPTIONAL) Uncompensated Relationships - Aravive; AstraZeneca; AstraZeneca; BMS; Genentech/Roche
 
Maria Isabel Carlo
Honoraria - OncLive/MJH Life Sciences; OncLive/MJH Life Sciences
Other Relationship - Prostate Cancer Foundation; Robert Wood Johnson Foundation
 
Andrea Knezevic
Consulting or Advisory Role - ByHeart
 
Laura Peralta
No Relationships to Disclose
 
Ying-Bei Chen
Consulting or Advisory Role - Inspirna
 
Mark Zucker
No Relationships to Disclose
 
Robert A Lefkowitz
No Relationships to Disclose
 
Eduard Reznik
No Relationships to Disclose
 
Neil J. Shah
Honoraria - MedNet, LLC; MedNet, LLC; MJH Life Sciences
Consulting or Advisory Role - Exelixis; Graticule; Merck Sharp & Dohme Corp.
Research Funding - Aravive (Inst); Exelixis
Travel, Accommodations, Expenses - Merck
 
Colette Ngozi Owens
No Relationships to Disclose
 
Deaglan Joseph McHugh
Honoraria - OncLive
Consulting or Advisory Role - Progenics
 
David H Aggen
Consulting or Advisory Role - Astellas Pharma; Boehringer Ingelheim; Seagen
Patents, Royalties, Other Intellectual Property - University of Illinois - Urbana Champaign
 
Andrew Leonard Laccetti
Consulting or Advisory Role - Bayer; Guidepoint Global; Third Bridge
Research Funding - Bayer; ESSA; Johnson & Johnson/Janssen
 
Ritesh R Kotecha
Consulting or Advisory Role - Eisai; Eisai
Research Funding - Allogene Therapeutics (Inst); Exelixis (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst)
 
Darren R. Feldman
Consulting or Advisory Role - BioNTech; Cigna
Research Funding - Astellas Pharma; Decibel Therapeutics (Inst); Telix Pharmaceuticals
Other Relationship - UpToDate
 
Robert J. Motzer
Consulting or Advisory Role - AstraZeneca; Aveo; Calithera Biosciences; Eisai; EMD Serono; Exelixis; Genentech/Roche; Incyte; Merck; Pfizer
Research Funding - Aveo (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb